Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:activities |
protease inhibitor
|
| gptkbp:appointed_by |
oral capsule
|
| gptkbp:approves |
gptkb:1996
gptkb:FDA |
| gptkbp:clinical_trial |
60% to 70%
|
| gptkbp:developed_by |
gptkb:Merck_&_Co.
|
| gptkbp:discontinued |
in some markets
|
| https://www.w3.org/2000/01/rdf-schema#label |
Indinavir
|
| gptkbp:ingredients |
C15 H22 N4 O4 S
|
| gptkbp:is_used_for |
treatment of HIV
|
| gptkbp:marketed_as |
Crixivan
|
| gptkbp:side_effect |
headache
nausea diarrhea kidney stones |
| gptkbp:bfsParent |
gptkb:Burroughs_Wellcome
|
| gptkbp:bfsLayer |
4
|